Session 2: Donor Selection

All of the relevant financial relationships listed for these individuals have been mitigated. Unless otherwise noted, speakers have nothing to disclose.

Moderators

Jasleen Kukreja, MD
Matthew Hartwig, MD

Presentations

  1. Size Matching and Donor Organ Quality Assessment
    Kewal Krishan, MD
     
  2. Appropriate Use of Marginal Donors
    Michael S. Mulligan, MD
     
  3. Organ Procurement Techniques—DBD, DCD, or NRP
    Sandra Lindstedt, MD, PhD
     
  4. Ex Vivo Lung Perfusion Platforms
    Kenneth R. McCurry, MD
     
  5. Hepatitis-C and Other Increased Risk Donors
    Errol L. Bush, MD
    Disclosure(s): Johnson & Johnson Ethicon: Advisory Board (Terminated, April 30, 2022)
     
  6. Panel Discussion
Activity summary
Available credit: 
  • 1.50 AMA PRA Category 1 Credit
  • 1.50 Participation
Activity opens: 
02/01/2024
Activity expires: 
02/15/2027
Cost:
$0.00
Rating: 
0

Available Credit

  • 1.50 AMA PRA Category 1 Credit
  • 1.50 Participation

Price

Cost:
$0.00
Please login or register to take this course.

All of the relevant financial relationships listed for these individuals have been mitigated. Unless otherwise noted, speakers have nothing to disclose.

Moderators

Jasleen Kukreja, MD
Matthew Hartwig, MD

Presentations

  1. Size Matching and Donor Organ Quality Assessment
    Kewal Krishan, MD
     
  2. Appropriate Use of Marginal Donors
    Michael S. Mulligan, MD
     
  3. Organ Procurement Techniques—DBD, DCD, or NRP
    Sandra Lindstedt, MD, PhD
     
  4. Ex Vivo Lung Perfusion Platforms
    Kenneth R. McCurry, MD
     
  5. Hepatitis-C and Other Increased Risk Donors
    Errol L. Bush, MD
    Disclosure(s): Johnson & Johnson Ethicon: Advisory Board (Terminated, April 30, 2022)
     
  6. Panel Discussion